BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25132454)

  • 1. The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
    Wills MR; Poole E; Lau B; Krishna B; Sinclair JH
    Cell Mol Immunol; 2015 Mar; 12(2):128-38. PubMed ID: 25132454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.
    Krishna BA; Poole EL; Jackson SE; Smit MJ; Wills MR; Sinclair JH
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
    Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
    J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent Cytomegalovirus-Driven Recruitment of Activated CD4+ T Cells Promotes Virus Reactivation.
    Jackson SE; Chen KC; Groves IJ; Sedikides GX; Gandhi A; Houldcroft CJ; Poole EL; Montanuy I; Mason GM; Okecha G; Reeves MB; Sinclair JH; Wills MR
    Front Immunol; 2021; 12():657945. PubMed ID: 33912186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.
    Groves IJ; Jackson SE; Poole EL; Nachshon A; Rozman B; Schwartz M; Prinjha RK; Tough DF; Sinclair JH; Wills MR
    Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus persistence.
    Goodrum F; Caviness K; Zagallo P
    Cell Microbiol; 2012 May; 14(5):644-55. PubMed ID: 22329758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleepless latency of human cytomegalovirus.
    Poole E; Sinclair J
    Med Microbiol Immunol; 2015 Jun; 204(3):421-9. PubMed ID: 25772624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro.
    Saffert RT; Kalejta RF
    J Virol; 2007 Sep; 81(17):9109-20. PubMed ID: 17596307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-Responsive Genes Are Targeted during the Establishment of Human Cytomegalovirus Latency.
    Elder EG; Krishna BA; Williamson J; Lim EY; Poole E; Sedikides GX; Wills M; O'Connor CM; Lehner PJ; Sinclair J
    mBio; 2019 Dec; 10(6):. PubMed ID: 31796538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus manipulation of latently infected cells.
    Sinclair JH; Reeves MB
    Viruses; 2013 Nov; 5(11):2803-24. PubMed ID: 24284875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34
    Crawford LB; Hancock MH; Struthers HM; Streblow DN; Yurochko AD; Caposio P; Goodrum FD; Nelson JA
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4⁺ T cells.
    Mason GM; Jackson S; Okecha G; Poole E; Sissons JG; Sinclair J; Wills MR
    PLoS Pathog; 2013; 9(10):e1003635. PubMed ID: 24130479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus: Latency and reactivation in the myeloid lineage.
    Sinclair J
    J Clin Virol; 2008 Mar; 41(3):180-5. PubMed ID: 18164651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular reservoirs of latent cytomegaloviruses.
    Reddehase MJ; Lemmermann NAW
    Med Microbiol Immunol; 2019 Aug; 208(3-4):391-403. PubMed ID: 31011793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective 4-Thiouracil Labeling of RNA Transcripts within Latently Infected Cells after Infection with Human Cytomegalovirus Expressing Functional Uracil Phosphoribosyltransferase.
    Roche KL; Nukui M; Krishna BA; O'Connor CM; Murphy EA
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspects of human cytomegalovirus latency and reactivation.
    Reeves M; Sinclair J
    Curr Top Microbiol Immunol; 2008; 325():297-313. PubMed ID: 18637513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus latency and reactivation: recent insights into an age old problem.
    Dupont L; Reeves MB
    Rev Med Virol; 2016 Mar; 26(2):75-89. PubMed ID: 26572645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex Interplay of the UL136 Isoforms Balances Cytomegalovirus Replication and Latency.
    Caviness K; Bughio F; Crawford LB; Streblow DN; Nelson JA; Caposio P; Goodrum F
    mBio; 2016 Mar; 7(2):e01986. PubMed ID: 26933055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antibodies in confining cytomegalovirus after reactivation from latency: three decades' résumé.
    Krmpotić A; Podlech J; Reddehase MJ; Britt WJ; Jonjić S
    Med Microbiol Immunol; 2019 Aug; 208(3-4):415-429. PubMed ID: 30923898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How understanding immunology contributes to managing CMV disease in immunosuppressed patients: now and in future.
    Sissons JG; Wills MR
    Med Microbiol Immunol; 2015 Jun; 204(3):307-16. PubMed ID: 25896527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.